Pascal Schneider
Pascal Schneider
Department of Immunobiology, University of Lausanne, Switzerland
Verified email at
Cited by
Cited by
Inhibition of death receptor signals by cellular FLIP
M Irmler, M Thome, M Hahne, P Schneider, K Hofmann, V Steiner, ...
Nature 388 (6638), 190-195, 1997
Fas triggers an alternative, caspase-8–independent cell death pathway using the kinase RIP as effector molecule
N Holler, R Zaru, O Micheau, M Thome, A Attinger, S Valitutti, JL Bodmer, ...
Nature immunology 1 (6), 489-495, 2000
Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations
F Mackay, SA Woodcock, P Lawton, C Ambrose, M Baetscher, ...
The Journal of experimental medicine 190 (11), 1697-1710, 1999
Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape
M Hahne, D Rimoldi, M Schröter, P Romero, M Schreier, LE French, ...
Science 274 (5291), 1363-1366, 1996
BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth
P Schneider, F MacKay, V Steiner, K Hofmann, JL Bodmer, N Holler, ...
The Journal of experimental medicine 189 (11), 1747-1756, 1999
Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors
M Thome, P Schneider, K Hofmann, H Fickenscher, E Meinl, F Neipel, ...
Nature 386 (6624), 517-521, 1997
Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
I Viard, P Wehrli, R Bullani, P Schneider, N Holler, D Salomon, T Hunziker, ...
Science 282 (5388), 490-493, 1998
The molecular architecture of the TNF superfamily
JL Bodmer, P Schneider, J Tschopp
Trends in biochemical sciences 27 (1), 19-26, 2002
IAP antagonists target cIAP1 to induce TNFα-dependent apoptosis
JE Vince, WWL Wong, N Khan, R Feltham, D Chau, AU Ahmed, ...
Cell 131 (4), 682-693, 2007
BAFF AND APRIL: a tutorial on B cell survival
F Mackay, P Schneider, P Rennert, J Browning
Annual review of immunology 21 (1), 231-264, 2003
BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF
JS Thompson, SA Bixler, F Qian, K Vora, ML Scott, TG Cachero, ...
Science 293 (5537), 2108-2111, 2001
Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren’s syndrome
J Groom, SL Kalled, AH Cutler, C Olson, SA Woodcock, P Schneider, ...
The Journal of clinical investigation 109 (1), 59-68, 2002
Cracking the BAFF code
F Mackay, P Schneider
Nature reviews immunology 9 (7), 491-502, 2009
Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity
P Schneider, N Holler, JL Bodmer, M Hahne, K Frei, A Fontana, ...
The Journal of experimental medicine 187 (8), 1205-1213, 1998
TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB
P Schneider, M Thome, K Burns, JL Bodmer, K Hofmann, T Kataoka, ...
Immunity 7 (6), 831-836, 1997
BAFF mediates survival of peripheral immature B lymphocytes
M Batten, J Groom, TG Cachero, F Qian, P Schneider, J Tschopp, ...
The Journal of experimental medicine 192 (10), 1453-1466, 2000
TRAIL receptor-2 signals apoptosis through FADD and caspase-8
JL Bodmer, N Holler, S Reynard, P Vinciguerra, P Schneider, P Juo, ...
Nature cell biology 2 (4), 241-243, 2000
Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans
U Salzer, HM Chapel, ADB Webster, Q Pan-Hammarström, ...
Nature genetics 37 (8), 820-828, 2005
MyD88, an adapter protein involved in interleukin-1 signaling
K Burns, F Martinon, C Esslinger, H Pahl, P Schneider, JL Bodmer, ...
Journal of biological chemistry 273 (20), 12203-12209, 1998
APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth
M Hahne, T Kataoka, M Schröter, K Hofmann, M Irmler, JL Bodmer, ...
The Journal of experimental medicine 188 (6), 1185-1190, 1998
The system can't perform the operation now. Try again later.
Articles 1–20